Tirzepatide

Tirzepatide (CAS 2023788-19-2) is a synthetic dual-agonist peptide supplied for laboratory and analytical research use only, and one of the most frequently referenced compounds in contemporary metabolic research literature.

Research background

Tirzepatide is described in the literature as a dual GIP and GLP-1 receptor agonist. Its dual-receptor activity has made it a common reference compound in incretin research, where investigators study receptor binding behaviour, signalling pathways and comparative activity against single-agonist peptides in controlled research models.

Specifications

• Compound: Tirzepatide
• CAS number: 2023788-19-2
• Appearance: Lyophilised white powder
• Purity: 99%+ verified by HPLC-MS
• Available size: 20mg
• Presentation: Sealed, tamper-evident vial

Testing and verification

Every batch undergoes independent third-party HPLC-MS analysis confirming identity, quantity and purity. Each lot carries a unique batch identifier with its Certificate of Analysis published on our Lab Results page for full traceability.

Handling and storage

Supplied lyophilised. Store sealed vials cold and protected from light. Standard laboratory handling practices apply.

Research use only. This material is intended strictly for laboratory and analytical research. It is not a medicine, supplement or therapeutic good, and is not for human or veterinary consumption.